Knight Capital Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Knight Capital Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$107K	Buy	+12,815	New	+$155K	﹤0.01%	2930

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Knight Capital Group's IRWD Position: Q2 2013 in Review

Knight Capital Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2013: 12,815 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2930 among its holdings.

129 funds tracked by Wall St. Rank hold IRWD as of Q2 2013.

Knight Capital Group held 12,815 shares of Ironwood Pharmaceuticals worth $107K as of Q2 2013.
Ironwood Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
Ironwood Pharmaceuticals made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2930 holding.
129 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.